The clinical integration system from Biomax provides a conceptual and computational infrastructure for evidence-based, disease-centric approaches to healthcare delivery. Reaching beyond current statistical patient evaluation methods and epidemiological predictions, this solution brings thousands of clinical data points and intrinsic and extrinsic parameters to the patient evaluation process.
The system is highly flexible and provides integrated knowledge management and analysis of diverse data using the versatile BioXM platform for patient stratification and targeted therapy.
Current clinical information systems are focused on accounting. In order to address interdisciplinary concepts of care in chronic diseases such as COPD it is required to rethink data acquisition. BioXM based clinical system provides an integrated environment to implement novel concepts of care that are built on a modular approach breaking down individual medical diagnostic and therapeutic activities into individual sessions. BioXM ensures over all integrity of planning, executing and monitoring diagnosis and intervention. To this regard the data acquisition and planning is tailored according to the specification of the medical personal that actually do the work.
Patent stratification is all about objectifying the overall patient health condition in light of the overall patient population of similar nature. Patients need to be characterized by many parameters at the same time to determine the best therapeutic path forward. Clinical decision support (CDS) is indispensable in order to improve treatment of patients with depression (individualized treatment). Risk assessment of therapy resistance (already at the time of admission to the hospital) allows for less „Trial-and-Error“- treatments, reduction of treatment time, less risk for chronification and thus reduction of treatment- and social costs.
The integration challenge between clinics is unmastered and will remain a challenge especially across borders. Disease maps turn the integration problem around, the knowledge and drivers of a specific disease condition is integrated and harmonized. Thus, data from different clinical organizations only need to be mapped against the disease map. As a result, every clinical researcher can share and benefit from the findings of his collaborators instantaneously. This is important in particular in the field of response to pandemic threads, where time is critical, for example to establish a ZIKV drug host factor network.
Today clinical research can no longer take place in isolation in order to assess a patient also the geographical and epidemiological background of a disease situation is of relevance in order to properly asses the patient´s disease state comprehensively. BioXM allows to capture and aggregate that information from public resources and relate this information internal clinical records.